Диссертация (Качество жизни и респираторная функция у пациентов, излеченных от туберкулеза легких), страница 34

Acomparison of the level of dyspnea vs disease severity in indicating thehealth-related quality of life of patients with COPD. // Chest. - 1999.- Vol.116. - N.6. - P.1632-1637.228. Hamilton AL, Killian KJ, Summers E, Jones NL. Symptom intensity andsubjective limitation to exercise in patients with cardiorespiratorydisorders. // Chest. – 1996.

– Vol.110. – N.5. – P.1255-1263.229. Hansen JE, Sun XG, Wasserman K. Discriminating measures and normalvalues for expiratory obstruction. // Chest. – 2006. – Vol.129. –N.2. –P.369-377.230. Hegewald MJ, Lefor MJ, Jensen RL, Crapo RO, Kritchevsky SB,Haggerty CL, Bauer DC, Satterfield S, Harris T.

Peak expiratory flow isnot a quality indicator for spirometry: peak expiratory flow variability andFEV1 are poorly correlated in an elderly population. // Chest. – 2007. –Vol.131. – N.5. - P.1494-1499.231. Hernandes NA, Wouters EF, Meijer K, et al. Reproducibility of 6-minutewalking test in patients with COPD. // Eur Respir J. – 2010. – Vol.38. –N.2. – P.261-267.232.

Hicks A, Muthukumarasamy S, Maxwell D, Howlett D. Chronic inactivepulmonary tuberculosis and treatment sequelae: chest radiographicfeatures. // Int J Tuber Lung Dis. – 2014. – Vol.18. – N.2. – P.128-133.273233. Hnizdo E, Singh T, Churchyard. Chronic pulmonary functionimpairment caused by initial and recurrent pulmonary tuberculosisfollowing treatment. // Thorax.

– 2000. – Vol.55. – N.1. – P.32-55.234. Hodgkin JE, Celli BR, Connors GL. Pulmonary rehabilitation: guidelinesto success. Ed 3. Lippincott Williams & Wilkins, 2000.235. Holland AE, Spruit MA, Troosters T, Puhan MA, Pepin V, Saey D,McCormack MC, Carlin BW, Sciurba FC, Pitta F, Wanger J, MacIntyre N,Kaminsky DA, Culver BH, Revill SM, Hernandes NA, Andrianopoulos V,Camillo CA, Mitchell KE, Lee AL, Hill CJ, Singh SJ. An official EuropeanRespiratory Society/American Thoracic Society technical standard: fieldwalking tests in chronic respiratory disease.

// Eur Respir J. – 2014. –Vol.44. – N. 6. – P.1428-1446.236. Hughes JMB, Pride NB. Lung function tests: Physiological Principlesand Clinical Applications. Harcourt Brace and Co Ltd, 1999. Pp 314.237. Hunt SM, McEwen J, McKenna SP. Measuring health status: a new toolfor clinicians and epidemiologists.

// J Royal Coll Gen Pract. – 1985. – Vol.35. – N.273. - P. 185-88.238. Hwang YI, Kim JH, Lee CY, Park S, Park YB, Jang SH, Kim CH, ShinTR, Park SM, Sim YS, Kim DG, Lee MG, Hyun IG, Jung KS. Theassociation between airflow obstruction and radiologic change bytuberculosis. // J Thorac Dis. – 2014. – Vol.6. – N.5.

– P. 471-476.239. Jasmer RM, Bozeman L, Schwartzman K, Cave MD, Saukkonen JJ,Metchock B, Khan A, Burman WJ; Tuberculosis Trials Consortium.Recurrent tuberculosis in the United States and Canada: relapse orreinfection? // Am J Respir Crit Care Med. – 2004. – Vol. 170. – N.12. – P.1360-1366.240. Jenkins S, Cecins NM. Six-minute walk test in pulmonary rehabilitation:do all patients need a practice test? // Respirology. – 2010. – Vol.

15. – N.8.– P. 1192-1196.274241. Jick SS, Lieberman ES, Rahman MU, Choi HK. Glucocorticoid use,other associated factors, and the risk of tuberculosis. // Arthritis Rheum. –2006. – Vol. 55. – N. 1. – P. 19-26.242. Jithoo A, Enright PL, Burney P, Buist AS, Bateman ED, Tan WC,Studnicka M, Mejza F, Gillespie S, Vollmer WM; BOLD CollaborativeResearch Group. Case-finding options for COPD: results from the Burdenof Obstructive Lung Disease study. // Eur Respir J. – 2013. – Vol. 41.

–N.3. – P. 548-55.243. Johns DP, Walters JA, Walters EH. Diagnos and early detection ofCOPD using spirometry. // J Thorac Dis. – 2014. – Vol.6. – N.11. –P.1567-1569.244. Johnson JD, Theurer WM. A stepwise approach to the interpretation ofpulmonary function tests. // Am Fam Physician. – 2014. – Vol.89. – N.5.

–P.359-366.245. Jones PW, Quirk FH, Baveystock CM, Littlejohns P. A self-completemeasure of health status for chronic airflow limitation. // Am Rev RespirDis. - 1992. - Vol. 145. – N. 6. - P. 1321-1327.246. Jones PW. St. George’s Respiratory Questionnaire: MCID. // COPD. 2005. - Vol. 2.

– N.1. - P. 75-79.247. Jordan TS, Spencer EM, Davies P. Tuberculosis, bronchiectasis andchronic airflow obstruction. // Respirology. – 2010. – Vol.15. – N.4. – P.623-628.248. Juniper EF, Guyatt GH, at al. Evaluation of impairment of health-relatedquality of life in asthma; development of a questionnaire for use in clinicaltrials. // Thorax. - 1992. - Vol. 47. – N.2. - P.76-83.249. Juniper EF, Guyatt GH, Willian A, Griffith LE. Determining a minimalimportant change in a disease-specific quality of life questionnaire.

// J ClinEpid. - 1994. - Vol. 47. – N.1. - P. 81-87.275250. Inghammar M, Ekbom A, Engström G, Ljungberg B, Romanus V,Löfdahl CG, Egesten A. COPD and the risk of tuberculosis--a populationbased cohort study. // PLoS One. – 2010. – Vol. 5. – N.4. P. e10138.251. Inghammar M, Löfdahl CG, Winqvist N, Ljungberg B, Egesten A,Engström G. Impaired pulmonary function and the risk of tuberculosis: apopulation-based cohort study.

// Eur Respir J. – 2011. – Vol. 37. – N. 5. P.1285-1287.252. Kazis LE, Anderson JJ, Meenan RF. Effect sizes for interpreting changesin health status. // Med Care. – 1989. – Vol. 27. –N. 3 Suppl. – P. S178-89.253.Khalid I, Morris ZQ, Khalid TJ, Nisar A, Digiovine B. Using spirometryto rule out restriction in patients with concomitant low forced vital capacityand obstructive pattern. // Open Respir Med J. – 2011. – Vol. 5.

P. 44-50.254. Killian KJ, Leblanc P, Martin DH, Summers E, Jones NL, Campbell EJ.Exercise capacity and ventilatory, circulatory, and symptom limitation inpatients with chronic airflow limitation. // Am Rev Respir Dis. – 1992. –Vol.146. – N.4. – P. 935-40.255. Ko Y, Lee YM, Lee HY, Lee YS, Song JW, Hong GY, Kim MY, LeeHK, Choi SJ, Shim EJ. Changes in lung function according to diseaseextent before and after pulmonary tuberculosis.

// Int J Tuberc Lung Dis. –2015. – Vol.19. – N.5. – P.589-595.256. Kupferberg DH, Kaplan RM, Slymen DJ, Ries AL. Minimal clinicallyimportant difference for the UCSВ Shortness of breath questionnaire. // JCardiolpulm Rehab. – 2005. – Vol. 25.

– N.6. - P. 370-377.257. Kuyken W, Orley J, Power M, at al. The World Health OrganizationQuality of Life assessment (WHOQOL): position paper from the WorldHealth Organization. // Soc Sci Med. – 1995. – Vol. 41. – N.10. –P. 14031409.258. Lam KB, Jiang CQ, Jordan RE, Miller MR, Zhang WS, Cheng KK, LamTH, Adab P. Prior TB, smoking, and airflow obstruction: a cross-sectional276analysis of the Guangzhou Biobank Cohort Study. // Chest. – 2010.

– Vol.137. – N. 3. – P. 593-600.259. Lareau SC, Carrieri-Kohlman V, Janson-Bjerklie S,Roos PJ.Development and testing of the pulmonary functional status and dyspneaquestionnaire (PFSDQ). // Heart Lung.-1994. - Vol. 23. – N.3. - P.242-250.260. Lareau SC, Meek PM, Roos PJ. Development and testing of the modifiedversion of the pulmonary functional status and dyspnea questionnaire.

//Heart Lung. - 1998. - Vol. 27. - N. 3. - P.159-168.261. Lee SW, Kim YS, Kim DS, Oh YM, Lee SD. The risk of obstructivelung disease by previous pulmonary tuberculosis in a country withintermediate burden of tuberculosis. // J Korean Med Sci. – 2011. – Vol.26. – N.2. – P. 268-273.262. Llewellin P, Sawyer G, Lewis S, Cheng S, Weatherall M, Fitzharris P,Beasley R. The relationship between FEV1 and PEF in the assessment ofthe severity of airways obstruction.

// Respirology. – 2002. – Vol. 7. – N.4.– P. 333-337.263. Long R. Pulmonary tuberculosis treated with directly observed therapy:serial changes in lung structure and function. // Chest. – 1998. – Vol. 113. –N.4. – P. 933-943.264. MaguireGP, Anstey NM, Ardian M, Waramori G, Tjitra E,Kenangalem E, Handojo T, Kelly PM. Pulmonary tuberculosis, impairedlung function, disability and quality of life in a high-burden setting. // Int JTuberc Lung Dis.

– 2009. – Vol. 13. – N. 12. – P. 1500-1506.265. Mahler DA, Weinberg DH, Wells CK, Feinstein AR. The measurementof dyspnea. Contents, interobserver agreement, and physiologic correlatesof two new clinical indexes. // Chest. – 1984. –Vol. 85. – N. 6. - P. 751858.266. Mahler DA. Dyspnea: diagnosis and management. // Clin Chest Med. –1987. – Vol. 8. – N. 2.

– P. 215-30.277267. Mahler DA, Jones PW. Measurement of dyspnea and quality of life inadvanced lung disease. // Clin Chest Med. - 1997. - Vol. 18. - N. 3. - P.457-469.268. Mahler DA, O'Donnell DE. Recent advances in dyspnea. // Chest. –2015. – Vol.147. – N.1. – P. 232-241.269. Maltais F, LeBlanc P, Jobin J, Berube C, Bruneau J, Carrier l, Breton MJ, Falardeau G, and Beleau R. Intensity of training and physiologicadaptation in patients with chronic obstructive pulmonary disease.

// Am JRespir Crit Care Med. – 1997. – Vol. 155. – N.2. - P. 555-561.270. Man WDC, Polkey MI, Donaldson N, Gray BJ and Moxham J.Community pulmonary rehabilitation after hospitatilisation for acuteexacerbations of COPD. // BMJ. – 2004. - Vol. 329. – N.7476. - P. 12091213.271. Mannino DM, Ford ES, Redd SC. Obstructive and restrictive lungdisease and functional limitation: data from the Third National Health andNutrition Examination. // J. Intern. Med. – 2003.

– Vol. 254. – N.6. - P.540-547.272. Mannino DM. Respiratory symptoms: A reason to obtain spirometry. //Respiratory Care. – 2006. – Vol. 51. – N. 10. – P. 1116-1117.273. Marra CA, Marra F, Cox VC, Palepu A, Fitzgerald JM. Factorsinfluencing quality of life in patients with active tuberculosis. // HealthQual Life Outcomes. – 2004. – Vol. 2. – P.

58.274. Marra CA, Marra F, Colley L, Moadebi S, Elwood RK, Fitzgerald JM.Health-related quality of life trajectories among adults with tuberculosis:differences between latent and active infection. // Chest. – 2008. – Vol.133. – N. 2. – P. 396-403.275. McGavin CR, Gupta SP, McHardy GJ.

Twelve-minute walking test forassessing disability in chronic bronchitis. // Br Med J 1976. – Vol.1. –N.6013. - P. 822-823.278276. McGavin CR, Artvinli M, Naoe H. Dyspnoea, disability, and distancewalked: comparison of estimates of exercise performance in respiratorydisease. // BMJ. – 1978. – Vol. 2 – N.6132. - P. 241-243.277. Medbø A, Melbye H. What role may symptoms play in the diagnosis ofairflow limitation? A study in an elderly population? // Scand J Prim HealthCare. – 2008. – Vol. 26.